Suppr超能文献

疫苗学的变革。

Transforming vaccinology.

机构信息

Biotecnopolo di Siena Foundation, Siena, Italy.

Moderna Therapeutics, Cambridge, MA 02139, USA.

出版信息

Cell. 2024 Sep 19;187(19):5171-5194. doi: 10.1016/j.cell.2024.07.021.

Abstract

The COVID-19 pandemic placed the field of vaccinology squarely at the center of global consciousness, emphasizing the vital role of vaccines as transformative public health tools. The impact of vaccines was recently acknowledged by the award of the 2023 Nobel Prize in Physiology or Medicine to Katalin Kariko and Drew Weissman for their seminal contributions to the development of mRNA vaccines. Here, we provide a historic perspective on the key innovations that led to the development of some 27 licensed vaccines over the past two centuries and recent advances that promise to transform vaccines in the future. Technological revolutions such as reverse vaccinology, synthetic biology, and structure-based design transformed decades of vaccine failures into successful vaccines against meningococcus B and respiratory syncytial virus (RSV). Likewise, the speed and flexibility of mRNA vaccines profoundly altered vaccine development, and the advancement of novel adjuvants promises to revolutionize our ability to tune immunity. Here, we highlight exciting new advances in the field of systems immunology that are transforming our mechanistic understanding of the human immune response to vaccines and how to predict and manipulate them. Additionally, we discuss major immunological challenges such as learning how to stimulate durable protective immune response in humans.

摘要

新冠疫情将疫苗学领域置于全球意识的中心,强调了疫苗作为变革性公共卫生工具的重要作用。疫苗的影响最近得到了承认,Katalin Kariko 和 Drew Weissman 因在 mRNA 疫苗的开发方面做出了开创性的贡献而获得 2023 年诺贝尔生理学或医学奖。在这里,我们提供了一个历史视角,介绍了过去两个世纪中导致约 27 种许可疫苗发展的关键创新,以及未来有望改变疫苗的最新进展。反向疫苗学、合成生物学和基于结构的设计等技术革命将几十年的疫苗失败转化为针对脑膜炎球菌 B 和呼吸道合胞病毒 (RSV) 的成功疫苗。同样,mRNA 疫苗的速度和灵活性也极大地改变了疫苗的开发,新型佐剂的进步有望彻底改变我们调节免疫的能力。在这里,我们重点介绍系统免疫学领域令人兴奋的新进展,这些进展正在改变我们对人类对疫苗的免疫反应的机制理解,以及如何预测和操纵这些反应。此外,我们还讨论了主要的免疫学挑战,例如学习如何在人类中刺激持久的保护性免疫反应。

相似文献

1
Transforming vaccinology.疫苗学的变革。
Cell. 2024 Sep 19;187(19):5171-5194. doi: 10.1016/j.cell.2024.07.021.
2
7
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
9
Establishment of human post-vaccination SARS-CoV-2 standard reference sera.建立人接种 SARS-CoV-2 疫苗后标准参考血清。
J Immunol Methods. 2024 Jul;530:113698. doi: 10.1016/j.jim.2024.113698. Epub 2024 May 31.
10
Efficacy and safety of COVID-19 vaccines.新型冠状病毒疫苗的有效性和安全性。
Cochrane Database Syst Rev. 2022 Dec 7;12(12):CD015477. doi: 10.1002/14651858.CD015477.

引用本文的文献

1
Leaf Saponins of as Powerful Vaccine Adjuvants.作为强效疫苗佐剂的[植物名称]叶皂苷
Pharmaceutics. 2025 Jul 25;17(8):966. doi: 10.3390/pharmaceutics17080966.
4
Challenges and opportunities in mRNA vaccine development against bacteria.抗细菌mRNA疫苗开发中的挑战与机遇。
Nat Microbiol. 2025 Aug;10(8):1816-1828. doi: 10.1038/s41564-025-02070-z. Epub 2025 Jul 29.

本文引用的文献

6
Integrated organ immunity: a path to a universal vaccine.整合器官免疫:通往通用疫苗之路。
Nat Rev Immunol. 2024 Feb;24(2):81-82. doi: 10.1038/s41577-024-00990-1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验